Article
Synergistic antitumor effects of the combined treatment with an HDAC6 inhibitor and a COX-2 inhibitor through activation of PTEN.
Oncology reports - 1 Nov 2017
Zhang Guanhua, Gan Ye-Hua
Abstract excerpt
Chemotherapy is one of the most effective non-surgical treatments for various types of tumor. Identifying different combinations of antitumor agents that can produce synergistic antitumor effects remains an important clinical strategy. In the present study, we showed that the combination of histone deacetylase 6 (HDAC6) inhibitor tubastatin A together with cyclooxygenase-2 (COX-2) inhibitor celecoxib resulted in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
